Published in J Clin Microbiol on July 01, 2001
Web resources for HIV type 1 genotypic-resistance test interpretation. Clin Infect Dis (2006) 5.90
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration. PLoS Med (2005) 3.17
Rationale and uses of a public HIV drug-resistance database. J Infect Dis (2006) 2.91
HIV-1 drug resistance mutations: an updated framework for the second decade of HAART. AIDS Rev (2008) 2.88
Distribution of human immunodeficiency virus type 1 protease and reverse transcriptase mutation patterns in 4,183 persons undergoing genotypic resistance testing. Antimicrob Agents Chemother (2004) 1.82
HIV-1 antiretroviral resistance: scientific principles and clinical applications. Drugs (2012) 1.70
Differences in resistance mutations among HIV-1 non-subtype B infections: a systematic review of evidence (1996-2008). J Int AIDS Soc (2009) 1.65
Consensus drug resistance mutations for epidemiological surveillance: basic principles and potential controversies. Antivir Ther (2008) 1.58
Mutation D30N is not preferentially selected by human immunodeficiency virus type 1 subtype C in the development of resistance to nelfinavir. Antimicrob Agents Chemother (2004) 1.54
Impact of nelfinavir resistance mutations on in vitro phenotype, fitness, and replication capacity of human immunodeficiency virus type 1 with subtype B and C proteases. Antimicrob Agents Chemother (2004) 1.23
Viremia and HIV-1 drug resistance mutations among patients receiving second-line highly active antiretroviral therapy in Chennai, Southern India. Clin Infect Dis (2012) 1.07
Testing genotypic and phenotypic resistance in human immunodeficiency virus type 1 isolates of clade B and other clades from children failing antiretroviral therapy. J Clin Microbiol (2002) 1.01
HIV Genetic Diversity and Drug Resistance. Viruses (2010) 0.96
Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C. Viruses (2010) 0.87
Expression, purification and preliminary X-ray crystallographic studies of the human immunodeficiency virus 1 subtype C protease. Acta Crystallogr Sect F Struct Biol Cryst Commun (2007) 0.80
Lead expansion and virtual screening of Indinavir derivate HIV-1 protease inhibitors using pharmacophoric - shape similarity scoring function. Bioinformation (2010) 0.80
HIV-1 diversity in an antiretroviral treatment naïve cohort from Bushbuckridge, Mpumalanga Province, South Africa. Virol J (2015) 0.78
R57K polymorphism in the human immunodeficiency virus type 1 protease as predictor of early virological failure in a cohort of antiretroviral-naive patients treated mostly with a nelfinavir-containing regimen. Antimicrob Agents Chemother (2003) 0.78
Drug resistance mutation profile and accumulation kinetics in human immunodeficiency virus-positive individuals infected with subtypes B and F failing highly active antiretroviral therapy are influenced by different viral codon usage patterns. Antimicrob Agents Chemother (2008) 0.78
Comparable long-term efficacy of Lopinavir/Ritonavir and similar drug-resistance profiles in different HIV-1 subtypes. PLoS One (2014) 0.78
Major HIV resistance mutations in untreated Romanian patients. J Med Life (2011) 0.76
Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel. JAMA (2000) 7.81
Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays. Nat Med (1996) 5.35
Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites. J Virol (1997) 3.64
Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database. Nucleic Acids Res (1999) 3.44
The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention. JAMA (1996) 2.85
Genotypic and phenotypic characterization of human immunodeficiency virus type 1 variants isolated from patients treated with the protease inhibitor nelfinavir. Antimicrob Agents Chemother (1998) 2.67
Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations in treatment-naive patients. J Clin Microbiol (2000) 1.70
Resistance mutations in protease and reverse transcriptase genes of human immunodeficiency virus type 1 isolates from patients with combination antiretroviral therapy failure. J Infect Dis (1998) 1.58
Detection of drug resistance associated mutations in HIV primary infection within the UK. AIDS (2000) 1.24
Sequence and drug susceptibility of subtype C protease from human immunodeficiency virus type 1 seroconverters in Zimbabwe. AIDS Res Hum Retroviruses (1999) 1.18
High frequency of non-B subtypes in newly diagnosed HIV-1 infections in Switzerland. J Acquir Immune Defic Syndr (1999) 1.17
At least five HIV-1 sequence subtypes (A, B, C, D, A/E) occur in England. AIDS Res Hum Retroviruses (1995) 1.10
Presence of human immunodeficiency virus (HIV) type 1, group M, non-B subtypes, Bronx, New York: a sentinel site for monitoring HIV genetic diversity in the United States. J Infect Dis (2000) 1.09
Recombinant strains of HIV type 1 in the United Kingdom. AIDS Res Hum Retroviruses (2001) 1.08
Artemis: sequence visualization and annotation. Bioinformatics (2000) 46.68
Rapid responses of British butterflies to opposing forces of climate and habitat change. Nature (2001) 8.75
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet (2009) 7.96
Comparative losses of British butterflies, birds, and plants and the global extinction crisis. Science (2004) 6.18
Automated DNA sequencing of the human HPRT locus. Genomics (1990) 5.92
Uptake of immunisation in district health authorities in England. Br Med J (Clin Res Ed) (1988) 4.37
Distribution of NHS funds between fundholding and non-fundholding practices. BMJ (1994) 4.05
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet (1996) 4.05
SOAP-based services provided by the European Bioinformatics Institute. Nucleic Acids Res (2005) 3.93
The PH domain: a common piece in the structural patchwork of signalling proteins. Trends Biochem Sci (1993) 3.89
Factors affecting quality of informed consent. BMJ (1993) 3.68
Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med (1987) 3.58
The teacher as observer and experimenter in the modification of disputing and talking-out behaviors. J Appl Behav Anal (1971) 3.36
Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group. Arch Intern Med (1999) 3.10
Teenagers' health concerns: implications for primary health care professionals. J R Coll Gen Pract (1989) 3.00
Fluconazole resistant candida in AIDS. J Infect (1991) 2.97
Mother Theresa's care for the dying. Lancet (1994) 2.72
Misuse of temazepam. BMJ (1992) 2.49
A semi-automated method for the reading of nucleic acid sequencing gels. Nucleic Acids Res (1982) 2.44
Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission. HIV Med (2001) 2.33
Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet (1988) 2.28
Hospitalised adult patients with Suspected 2009 H1N1 Infection at Regional Infectious Diseases Units in Scotland--most had alternative final diagnoses. J Infect (2009) 2.24
Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient. Gut (2000) 2.16
An outbreak of multi-drug-resistant tuberculosis in a London teaching hospital. J Hosp Infect (1998) 2.10
Cytomegalovirus infection in immunocompetent patients. Clin Infect Dis (2003) 2.09
Prevalence of substance misuse in first-episode psychosis. Br J Psychiatry (1999) 2.09
A randomized study of high-dose cytarabine in induction in acute myeloid leukemia. Blood (1996) 2.06
Information Technology for postgraduate education: survey of facilities and skills in the South West Deanery. Br J Obstet Gynaecol (1999) 2.04
Prefer diazepam for initial control of pre-eclamptic fits. BMJ (1995) 2.04
Upper abdominal pain in pregnancy may indicate pre-eclampsia. BMJ (1994) 2.04
Herpes simplex virus inhibits apoptosis through the action of two genes, Us5 and Us3. J Virol (1999) 2.02
Responses of butterflies to twentieth century climate warming: implications for future ranges. Proc Biol Sci (2002) 2.00
Effects of hormonal status on bone density in adolescent girls. J Clin Endocrinol Metab (1990) 1.99
New mutations associated with resistance not detected following zidovudine monotherapy in pregnancy when used in accordance with British HIV Association guidelines. HIV Med (2008) 1.99
Pre-eclampsia, antiretroviral therapy, and immune reconstitution. Lancet (2002) 1.95
Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working? J Infect (2000) 1.94
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. HIV Med (2003) 1.94
Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis. Am Rev Respir Dis (1993) 1.80
Quality improvement demands quality measurement. BJOG (2010) 1.78
Ocular manifestations of acquired immune deficiency syndrome. Ophthalmology (1989) 1.76
Compilation of DNA sequences of Escherichia coli (update 1991). Nucleic Acids Res (1991) 1.73
Birthing pools and the fetus. Lancet (1993) 1.73
Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group. Arthritis Rheum (2001) 1.68
Implications for HIV testing policy derived from combining data on voluntary confidential testing with viral sequences and serological analyses. Sex Transm Infect (2008) 1.66
Emergence and evolution of enfuvirtide resistance following long-term therapy involves heptad repeat 2 mutations within gp41. Antimicrob Agents Chemother (2005) 1.63
Increased incidence of psychotic disorders in migrants from the Caribbean to the United Kingdom. Psychol Med (1997) 1.61
Multicentric Castleman's disease in HIV infection. Int J STD AIDS (2006) 1.60
The nucleotide sequence of Saccharomyces cerevisiae chromosome XIII. Nature (1997) 1.59
Assignment of segments of the bacteriorhodopsin sequence to positions in the structural map. Biophys J (1983) 1.58
Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series. QJM (2009) 1.57
The nucleotide sequence of Saccharomyces cerevisiae chromosome IX. Nature (1997) 1.56
Excessive use of force by police: a survey of academic emergency physicians. Emerg Med J (2009) 1.56
Relationship between herpes simplex virus ulceration and CD4+ cell counts in patients with HIV infection. AIDS (1992) 1.56
The perception of biological motion by human infants. Science (1982) 1.54
British HIV Association guidelines for the management of HIV infection in pregnant women 2012. HIV Med (2012) 1.54
Effect of HIV posttest counseling on STD incidence. JAMA (1992) 1.53
Amphetamine toxicity: experience with 127 cases. J Emerg Med (1989) 1.53
The chronicity of symptoms and disability in Reiter's syndrome. An analysis of 131 consecutive patients. Ann Intern Med (1979) 1.53
Oral health of patients with hepatitis C virus infection: a pilot study. Oral Dis (2001) 1.52
Compilation of DNA sequences of Escherichia coli (update 1992). Nucleic Acids Res (1992) 1.52
Antigenic heterogeneity of lipid A of Haemophilus influenzae. Infect Immun (1985) 1.50
Left main intervention revisited: early and late outcome of PTCA and stenting. Cathet Cardiovasc Diagn (1997) 1.50
Statistical evaluation and biological interpretation of non-random abundance in the E. coli K-12 genome of tetra- and pentanucleotide sequences related to VSP DNA mismatch repair. Nucleic Acids Res (1992) 1.50
Cooperativity mutants of the gamma delta resolvase identify an essential interdimer interaction. Cell (1990) 1.49
Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients. Gut (2003) 1.48
Direct visualization and quantitation of cytomegalovirus-specific CD8+ cytotoxic T-lymphocytes in liver transplant patients. Transplantation (2000) 1.48
Loss of private health insurance among homosexual men with AIDS. Inquiry (1991) 1.46
Diagnosis and treatment of malaria in Britain. BMJ (1993) 1.45
The suicide drop--why? R Soc Health J (1975) 1.45
Interferon plus amantadine versus interferon alone in the treatment of naïve patients with chronic hepatitis C: a UK multicentre study. J Hepatol (2001) 1.42
Use of real-time PCR and fluorimetry to detect lamivudine resistance-associated mutations in hepatitis B virus. Antimicrob Agents Chemother (1999) 1.41
Interpartner reliability of reporting of recent sexual behaviors. Am J Epidemiol (1991) 1.41
Multiple follicular development associated with herbal medicine. Hum Reprod (1994) 1.41
Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in children. AIDS (2007) 1.40
Of knowledge and deception. J R Soc Med (2000) 1.40
Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosis. Clin Infect Dis (1996) 1.40
ECD--a totally integrated database of Escherichia coli K12. Nucleic Acids Res (1994) 1.39
HIV and hepatitis C coinfection within the CAESAR study. HIV Med (2004) 1.39
Syphilis in London circa 2004: new challenges from an old disease. Arch Dis Child (2005) 1.39
Intratubal injection of prostaglandin in ectopic pregnancy. Lancet (1993) 1.38
Outcomes and predicting response in anaemic chemotherapy patients treated with epoetin alfa. A multicentre, 4-month, open-label study in Australia and New Zealand. Intern Med J (2008) 1.38
Fever, nodulobullous eruption and swollen ears. Clin Exp Dermatol (2013) 1.38
Detection of early antibodies in human immunodeficiency virus infection by enzyme-linked immunosorbent assay, Western blot, and radioimmunoprecipitation. J Clin Microbiol (1987) 1.37
Ocular adnexal lymphoproliferative disease: a series of 73 cases. Clin Experiment Ophthalmol (2001) 1.36
Compilation of DNA sequences of Escherichia coli (update 1990). Nucleic Acids Res (1990) 1.36
Recreational drug use and sexual behavior change in a cohort of homosexual men. The Multicenter AIDS Cohort Study (MACS). AIDS (1990) 1.36
Seroconversion in patients attending sexually transmitted disease clinics. AIDS (1994) 1.34
HIV-1 infection: no evidence of cognitive decline during the asymptomatic stages. The Multicenter AIDS Cohort Study. Neurology (1990) 1.34
Compilation of DNA sequences of Escherichia coli (update 1993). Nucleic Acids Res (1993) 1.34
Rheumatoid arthritis synovial membrane contains a 62,000-molecular-weight protein that shares an antigenic epitope with the Epstein-Barr virus-encoded associated nuclear antigen. J Clin Invest (1986) 1.34
Updated European recommendations for the clinical use of HIV drug resistance testing. Antivir Ther (2004) 1.28
Further developments in binocular summation. Percept Psychophys (1981) 1.27
HSV and glycoprotein J inhibit caspase activation and apoptosis induced by granzyme B or Fas. J Immunol (2001) 1.26
Zidovudine phosphorylation in HIV-infected patients and seronegative volunteers. AIDS (1994) 1.25
Clinical efficiency in a simulated emergency and relationship to team behaviours: a multisite cross-sectional study. BJOG (2011) 1.24
Adaptation to invisible gratings and the site of binocular rivalry suppression. Nature (1974) 1.24
Prediction of response to antiretroviral therapy by human experts and by the EuResist data-driven expert system (the EVE study). HIV Med (2010) 1.24
Pearls & Oy-sters: The medial longitudinal fasciculus in ocular motor physiology. Neurology (2008) 1.24
Detection of drug resistance associated mutations in HIV primary infection within the UK. AIDS (2000) 1.24